1. Goldberg SN, Livraghi T, Solbiati L, Gazelle GS. Gazelle GS, Saini S, Mueller PR, editors. In-situ ablation of focal hepatic neoplasms. Hepatobiliary and pancreatic radiology: imaging and intervention. 1997. New York: Thieme;470–502.
2. Curley SA, Izzo F, Ellis LM, Vauthey JN, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000. 232:381–391.
3. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg. 1999. 230:1–8.
4. Lim HK. Radiofrequency thermal ablation of hepatocellular carcinomas. Korean J Radiol. 2000. 1:175–184.
5. Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol. 1996. 167:759–768.
6. Dodd GD, Frank MS, Aribandi M, Chopra S, Chintapalli KN. Radiofrequency thermal ablation: computer analysis created by overlapping ablations. AJR Am J Roentgenol. 2002. 177:777–782.
7. Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided radiofrequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology. 1997. 202:195–203.
8. Sironi S, Livraghi T, Meloni F, Cobelli FD, Ferrero C, Maschio AD. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR Am J Roentgenol. 1999. 173:1225–1229.
9. Rosenthal DI, Hornicek FJ, Wolfe MW, et al. Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am. 1998. 80:815–821.
10. Gervais DA, McGovern FJ, Wood BJ, et al. Radiofrequency ablation of renal cell carcinoma: early clinical experience. Radiology. 2000. 217:665–672.
11. Jeffrey SS, Birdwell RL, Ikeda DM, et al. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg. 1999. 134:1064–1068.
12. Anzai Y, Lufkin R, DeSalles A, et al. Preliminary experience with MR-guided thermal ablation of brain tumors. AJNR Am J Neuroradiol. 1995. 16:39–48.
13. Zagoria RJ, Chen MY, Kavanagh PV, Torti FM. Radiofrequency ablation of lung metastases from renal cell carcinoma. J Urol. 2001. 166:1827–1828.
14. Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol. 2000. 174:57–59.
15. Goldberg SN, Gazelle GS, Compton CC, McLoud TC. Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol. 1995. 2:776–784.
16. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, McLoud TC. Radiofrequency tissue ablation of VX2 tumor nodules in the rabbit lung. Acad Radiol. 1996. 3:929–935.
17. Miao Y, Ni Y, Bosmans H, et al. Radiofrequency ablation for eradication of pulmonary tumor in rabbits. J Surg Res. 2001. 99:265–271.
18. Livraghi T, Goldberg SN, Monti F, et al. Saline-enhanced radiofrequency tissue ablation in the treatment of liver metastases. Radiology. 1997. 202:205–210.
19. Miao Y, Ni Y, Mulier S, et al. Ex-vivo experiment on radiofrequency liver ablation with saline infusion through a screw-tip cannulated electrode. J Surg Res. 1997. 71:19–24.
20. Haaga JR. Haaga JR, Lanzieri CF. Interventional CT-guided procedures. Computed tomography and magnetic resonance imaging of the whole body. 1994. 3rd ed. St.Louis: Mosby;1572–1693.
21. Goldberg SN, Stein M, Gazelle GS, Sheiman RG, Kruskal JB, Clouse ME. Percutaneous radiofrequency tissue ablation: optimization of pulsed-RF technique to increase coagulation necrosis. J Vasc Interv Radiol. 1999. 10:907–916.
22. Lee JD, Lee JM, Kim SW, Kim CS, Mun WS. MR imaging-histopathologic correlation of radiofrequency thermal ablation lesion in a rabbit liver model: observation during acute and chronic stages. Korean J Radiol. 2001. 2:151–158.
23. Ginsberg RJ, Vokes EE, Raben A. Pass HI, Mitchell JB, Johnson DH, Turrisi AT, editors. Cancer of the lung: non-small cell lung cancer. Cancer: principles and practice of oncology. 1996. 5th ed. Philadelphia: Lippincott-Raven;849–857.
24. Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer. 1999. 86:1867–1876.
25. Downey RJ. Surgical management of lung cancer. J Thorac Imaging. 1999. 14:266–269.
26. Moore DF Jr, Lee JS. Pass HD, Mitchell JB, Johnson DH, Turrisi AT, editors. Staging and prognostic factors: non-small cell lung cancer. Lung cancer: principles and practice. 1996. Philadelphia: Lippincott-Raven;481–494.
27. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol. 2000. 174:323–331.
28. Haines DE, Verow AF. Observations on electrode-tissue interface temperature and effect on electrical impedance during radiofrequency ablation of ventricular myocardium. Circulation. 1990. 82:1034–1038.
29. Geddes LA, Baker LE. The specific resistance of biological material-a compendium of data for the biomedical engineer and physiologist. Med Biol Eng. 1967. 5:271–293.
30. Gazelle GS, Goldberg SN, Solbiati L, et al. Tumor ablation with radio-frequency energy. Radiology. 2000. 217:633–646.
31. Miao Y, Ni Y, Yu J, Marchal G. A comparative study on validation of a novel cooled-wet electrode for radiofrequency liver ablation. Invest Radiol. 2000. 35:438–444.
32. Boehm T, Malich A, Goldberg SN, et al. Radio-frequency tumor ablation: internally cooled electrode versus saline-enhanced technique in an aggressive rabbit tumor model. Radiology. 2002. 222:805–813.
33. Goldberg SN, Ahmed M, Gazelle GS, et al. Radio-frequency thermal ablation with NaCl solution injection: effect of electrical conductivity on tissue heating and coagulation phantom and porcine liver study. Radiology. 2001. 219:157–165.
34. Shennib HA, Landreneau R, Mulder DS, et al. Video-assisted thoracoscopic wedge resection of T1 lung cancer in high-risk patients. Ann Surg. 1993. 218:555–560.
35. Landreneau RJ, Sugarbaker D, Mack MJ, et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small cell lung cancer. J Thorac Cardiovasc Surg. 1997. 113:691–700.
36. Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg. 1995. 60:615–623.